Search Within

Gary Ulaner

Formats
  1. Journal Article (95)
  2. Meeting Abstract (39)
  3. Miscellaneous (5)
  4. Review (4)
  5. Editorial (2)
  6. Book Whole (1)
  7. Guidelines (1)
Groups
  1. Molecular Imaging and Therapy Service (147)
  2. Radiology, Department of (147)
  3. Department of Medicine (75)
  4. Solid Tumor Oncology Division (60)
  5. GSK Faculty (59)
  6. Epidemiology and Biostatistics (46)

More Groups

People
  1. David Hyman (22)
  2. Christopher Riedl (21)
  3. Maxine Jochelson (21)
  4. Jason Lewis (20)
  5. Maura Dickler (19)
  6. Komal Jhaveri (18)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (12)
  6. 2020 (21)

More Years

Publications
  1. Journal of Nuclear Medicine (24)
  2. Clinical Nuclear Medicine (23)
  3. Journal of Clinical Oncology (16)
  4. Cancer Research (8)
  5. PET Clinics (7)
  6. European Journal of Nuclear Medicine and Molecular Imaging (6)

More Publications

Publishers
  1. Lippincott Williams & Wilkins (27)
  2. Society of Nuclear Medicine (24)
  3. American Society of Clinical Oncology (16)
  4. Elsevier Inc. (16)
  5. American Association for Cancer Research (12)
  6. Springer (8)

More Publishers

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FDG-avid intrathecal inflammation following administration of intrathecal methotrexate
    Journal Article

    Hogan, M. P.; Osborne, J.; Ulaner, G. A.
    Clinical Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients
    Journal Article

    Marinelli, B.; Espinet-Col, C.; Ulaner, G. A.; McArthur, H. L.; Gonen, M.; Jochelson, M.; Weber, W. A.
    American Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Unilateral suppression of brown fat on FDG PET/CT in Horner syndrome
    Journal Article

    Ulaner, G. A.; Samstein, R.; Cahlon, O.; Weber, W. A.; Rimner, A.
    Clinical Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Initial results of a prospective clinical trial of (18)F-fluciclovine PET/CT in newly diagnosed invasive ductal and invasive lobular breast cancers
    Journal Article

    Ulaner, G. A.; Goldman, D. A.; Gönen, M.; Pham, H.; Castillo, R.; Lyashchenko, S. K.; Lewis, J. S.; Dang, C.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using 89Zr-trastuzumab PET/CT
    Journal Article

    Ulaner, G. A.; Hyman, D. M.; Ross, D. S.; Corben, A.; Chandarlapaty, S.; Goldfarb, S.; McArthur, H.; Erinjeri, J. P.; Solomon, S. B.; Kolb, H.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer
    Journal Article

    Ulaner, G. A.; Castillo, R.; Goldman, D. A.; Wills, J.; Riedl, C. C.; Pinker-Domenig, K.; Jochelson, M. S.; Gönen, M.
    European Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • The impact that number of analyzed metastatic breast cancer lesions has on response assessment by (18)F-FDG PET/CT using PERCIST
    Journal Article

    Pinker, K.; Riedl, C. C.; Ong, L.; Jochelson, M.; Ulaner, G. A.; McArthur, H.; Dickler, M.; Gönen, M.; Weber, W. A.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation
    Journal Article

    Hatzoglou, V.; Yang, T. J.; Omuro, A.; Gavrilovic, I.; Ulaner, G.; Rubel, J.; Schneider, T.; Woo, K. M.; Zhang, Z.; Peck, K. K.; more...
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after 90Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0
    Journal Article

    Shady, W.; Kishore, S.; Gavane, S.; Do, R. K.; Osborne, J. R.; Ulaner, G. A.; Gonen, M.; Ziv, E.; Boas, F. E.; Sofocleous, C. T.
    European Journal of Radiology (2016)

    Fulltext@MSK | Save